Key facts
- Anterior’s last known valuation is $151.2M (Feb 2026).
- It has raised $63.3M; the latest was Early Stage VC ($40.0M) in Feb 2026.
- Notable investors include Sequoia Capital, New Enterprise Associates, Avra, Ventures Together, FPV Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Anterior
- ·The full record, as it builds
Funding rounds
No funding rounds for Anterior are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anterior
Developer of a clinical AI platform designed to transform and automate health plan workflows with measurable results. The company's platform offers modular AI actions, configurable workflow automation, and clinically validated models with transparent orchestration, enabling health plans to reduce administrative burden, improve clinical accuracy, and achieve faster operational efficiency.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 8
- Website
- anterior.com/
- Ownership
- Privately Held (backing)
Anterior doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anterior shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anterior in its N-PORT filings yet. We sweep new filings monthly.